Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zannetti

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Bone Marrow Transplantation|November 27, 2019
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myelomaGiulia Tolomelli, Katia Mancuso, Paola Tacchetti, et al.
Bone Marrow Transplantation|February 3, 2015
Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantationA Brioli, G Perrone, F Patriarca, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 6, 2024
Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cellsAngela Filograna, Stefano De Tito, Matteo Lo Monte, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|October 5, 2023
IROCA-TES: Improving Quality in Radiation Oncology through Clinical Audits - Training and Education for StandardizationJulian Malicki, Carla Lopes Castro, Magdalena Fundowicz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 25, 2025
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study - ATLANTIS part ILuca Nicosia, Marco Lorenzo Bonù, Ilaria Angelicone, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2025
RT for the management of locally advanced rectal cancer: Don't throw the baby with the bath water!Luca Nicosia, Marco Lorenzo Bonù, Ilaria Angelicone, et al.
Gynecologic Oncology|October 26, 2021
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR)Olivier Trédan, Magali Provansal, Cyril Abdeddaim, et al.
Leukemia|October 23, 2015
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active diseaseE Zamagni, C Nanni, F Gay, et al.
NPJ Genomic Medicine|April 23, 2026
Immuno-molecular features associated with exceptional recurrence-free survivorship from Ovarian Cancer in the pre-PARP eraFélix Blanc-Durand, Elisa Yaniz Galende, Gwénaël Ferron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2019
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I studyF Joly, D Ahmed-Lecheheb, E Kalbacher, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Bone Marrow Transplantation|November 27, 2019
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myelomaGiulia Tolomelli, Katia Mancuso, Paola Tacchetti, et al.
Bone Marrow Transplantation|February 3, 2015
Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantationA Brioli, G Perrone, F Patriarca, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 6, 2024
Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cellsAngela Filograna, Stefano De Tito, Matteo Lo Monte, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|October 5, 2023
IROCA-TES: Improving Quality in Radiation Oncology through Clinical Audits - Training and Education for StandardizationJulian Malicki, Carla Lopes Castro, Magdalena Fundowicz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 25, 2025
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study - ATLANTIS part ILuca Nicosia, Marco Lorenzo Bonù, Ilaria Angelicone, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2025
RT for the management of locally advanced rectal cancer: Don't throw the baby with the bath water!Luca Nicosia, Marco Lorenzo Bonù, Ilaria Angelicone, et al.
Gynecologic Oncology|October 26, 2021
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR)Olivier Trédan, Magali Provansal, Cyril Abdeddaim, et al.
Leukemia|October 23, 2015
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active diseaseE Zamagni, C Nanni, F Gay, et al.
NPJ Genomic Medicine|April 23, 2026
Immuno-molecular features associated with exceptional recurrence-free survivorship from Ovarian Cancer in the pre-PARP eraFélix Blanc-Durand, Elisa Yaniz Galende, Gwénaël Ferron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2019
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I studyF Joly, D Ahmed-Lecheheb, E Kalbacher, et al.
Pageof 27